Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-168

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 168 Last

Share
Profile

Follow
vwboy

5,645 Posts.

365

04/05/17

10:03

Post #: 24461439
Share

Originally posted by Bocholt ↑

It would in fact be inappropriate to sign any agreement now if you were a Telehealth company or even as RAP. It would set our price in the market and expectations, good for us maybe but a material risk if we didnt get FDA, and why would a Telehealth company make it public they have signed an agreement, if they were public it would be factored into their share price and again if we didnt get FDA it would be a significant risk.
Even if there have been handshakes done, it wouldnt be prudent as a Director to make any statements, and in fact the ASX might refuse to publish it. The chair of Fortesque Metals was charged by ASIC for making claims about a funding arrangement which was not honoured, so any claims that have preconditions such as FDA could be construed very differently by either party ( im sure there are examples the other way too, but as a Director I wouldnt announce it). Once we get FDA, I think all hell will break loose, but until then, sit tight dont let any tree shakers get your shares, and dont panic.

Expand

Disagree with you for once. Mou's are signed/agreed to all the time with certain milestones attached.
Seeing as they don't want to be bound by individual contracts though it should not stop a large Telehealth company from stating if our product works, they would use it. That would kick our share price along....imo.

RAP Price at posting: 30.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

FFM

Firefly positioned for copper growth in Canada ahead of resource update

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 39 more messages in this thread...

First 168 Last

Add RAP (ASX) to my watchlist

Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-168

Top Stories

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News